1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Mccoy, M.A. Stavridi, E.S. Waterman, J.L.F. Wieczorek, A. Opella, S.J. Halezonetis, T.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking UK EMBO J. EMJODG 0897 0261-4189 16 6230 6236 10.1093/emboj/16.20.6230 9321402 Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain. 1997 10.2210/pdb1a1u/pdb pdb_00001a1u 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4210.639 P53 OLIGOMERIZATION M40K, F41I, L44Y 2 man polymer no no DGEYFTLQIRGRERFEKIREYNEALELKDAQAGKE DGEYFTLQIRGRERFEKIREYNEALELKDAQAGKE A,C polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample P53 TUMOR SUPPRESSOR 9606 Homo sapiens 562 Escherichia coli database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_sheet repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1998-04-08 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_sheet.number_strands Y BNL 1997-12-16 REL NO VIOLATIONS 40 1 HNCA HNCOCA CBCACONH HNCACB 3D 15N-EDITED TOCSY-HMQC 3D 15N-EDITED NOESY-HMQC HCCH-TOCSY 2D NOESY 2D COSY 2D TOCSY 3D 13C-EDITED NOESY 3D 13C-EDITED 13C-FILTERED HMQC-NOESY HNHA HMQC-J HNCA-J 7.0 313 K DETAILS CAN BE FOUND IN EMBO J., 16, 6230-6236 (1997). DG-SA BRUNGER refinement X-PLOR structure solution X-PLOR 600 Bruker DMX600 750 Bruker DMX750 n 1 24 A n 2 25 A GLU 26 n 3 GLU 26 A TYR 27 n 4 TYR 27 A PHE 28 n 5 PHE 28 A THR 29 n 6 THR 29 A LEU 30 n 7 LEU 30 A GLN 31 n 8 GLN 31 A ILE 32 n 9 ILE 32 A ARG 33 n 10 ARG 33 A GLY 34 n 11 GLY 34 A ARG 35 n 12 ARG 35 A GLU 36 n 13 GLU 36 A ARG 37 n 14 ARG 37 A PHE 38 n 15 PHE 38 A GLU 39 n 16 GLU 39 A LYS 40 n 17 LYS 40 A ILE 41 n 18 ILE 41 A ARG 42 n 19 ARG 42 A GLU 43 n 20 GLU 43 A TYR 44 n 21 TYR 44 A ASN 45 n 22 ASN 45 A GLU 46 n 23 GLU 46 A ALA 47 n 24 ALA 47 A LEU 48 n 25 LEU 48 A GLU 49 n 26 GLU 49 A LEU 50 n 27 LEU 50 A LYS 51 n 28 LYS 51 A ASP 52 n 29 ASP 52 A ALA 53 n 30 ALA 53 A GLN 54 n 31 GLN 54 A n 32 55 A n 33 56 A n 34 57 A n 35 58 A n 1 24 C n 2 25 C GLU 26 n 3 GLU 26 C TYR 27 n 4 TYR 27 C PHE 28 n 5 PHE 28 C THR 29 n 6 THR 29 C LEU 30 n 7 LEU 30 C GLN 31 n 8 GLN 31 C ILE 32 n 9 ILE 32 C ARG 33 n 10 ARG 33 C GLY 34 n 11 GLY 34 C ARG 35 n 12 ARG 35 C GLU 36 n 13 GLU 36 C ARG 37 n 14 ARG 37 C PHE 38 n 15 PHE 38 C GLU 39 n 16 GLU 39 C LYS 40 n 17 LYS 40 C ILE 41 n 18 ILE 41 C ARG 42 n 19 ARG 42 C GLU 43 n 20 GLU 43 C TYR 44 n 21 TYR 44 C ASN 45 n 22 ASN 45 C GLU 46 n 23 GLU 46 C ALA 47 n 24 ALA 47 C LEU 48 n 25 LEU 48 C GLU 49 n 26 GLU 49 C LEU 50 n 27 LEU 50 C LYS 51 n 28 LYS 51 C ASP 52 n 29 ASP 52 C ALA 53 n 30 ALA 53 C GLN 54 n 31 GLN 54 C n 32 55 C n 33 56 C n 34 57 C n 35 58 C author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ASP 24 A ASP 1 1 Y 1 A GLY 25 A GLY 2 1 Y 1 A ALA 55 A ALA 32 1 Y 1 A GLY 56 A GLY 33 1 Y 1 A LYS 57 A LYS 34 1 Y 1 A GLU 58 A GLU 35 1 Y 1 C ASP 24 B ASP 1 1 Y 1 C GLY 25 B GLY 2 1 Y 1 C ALA 55 B ALA 32 1 Y 1 C GLY 56 B GLY 33 1 Y 1 C LYS 57 B LYS 34 1 Y 1 C GLU 58 B GLU 35 1 Y 1 A C HG1 HG1 THR THR 29 29 1.35 1 A TYR 27 -73.06 -75.29 1 A ILE 32 -126.69 -70.56 1 A ARG 33 88.84 92.44 1 A ALA 53 -87.04 -87.30 1 C TYR 27 -74.66 -75.64 1 C ILE 32 -128.13 -69.67 1 C ARG 33 88.15 94.28 1 C ALA 53 -85.72 -86.22 model building X-PLOR refinement X-PLOR phasing X-PLOR SOLUTION STRUCTURE DETERMINATION OF A P53 MUTANT DIMERIZATION DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1 N N 1 N N A ARG 35 A ARG 12 HELX_P A ASP 52 A ASP 29 1 1 18 C ARG 35 B ARG 12 HELX_P C ASP 52 B ASP 29 1 2 18 ANTI-ONCOGENE P53, OLIGOMERIZATION DOMAIN, HUMAN, ANTI-ONCOGENE P53_HUMAN UNP 1 324 P04637 324 358 1A1U 24 58 P04637 A 1 1 35 324 358 1A1U 24 58 P04637 C 1 1 35 1 A THR 29 A THR 6 A GLN 31 A GLN 8 1 P 1